Tech Center 3600 • Art Units: 1637 1681 3619
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18447749 | METHODS AND COMPOSITIONS FOR DETECTING NUCLEIC ACID VARIANTS | Non-Final OA | Guardant Health, Inc. |
| 18653613 | METHODS AND COMPOSITIONS FOR SPATIAL ASSAY | Non-Final OA | 10x Genomics, Inc. |
| 18418967 | METHODS OF MAKING GENE EXPRESSION LIBRARIES | Non-Final OA | 10x Genomics, Inc. |
| 17956596 | METHODS AND KITS FOR IDENTIFYING, DIAGNOSING AND TREATING PROSTATE CARCINOMAS | Final Rejection | 10x Genomics, Inc. |
| 18043012 | PORTABLE DETECTION OF SARS-COV-2 USING UNIMOLECULAR APTASENSORS | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 17879871 | Ultraspecific Nucleic Acid Sensors for Low-Cost Liquid Biopsies | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 17557010 | METHOD FOR PROVIDING QUANTITATIVE INFORMATION OF TARGETS AND DEVICE USING THE SAME | Final Rejection | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18403634 | TUMOR SUPPRESSOR SP0495 | Non-Final OA | The Chinese University of Hong Kong |
| 18468298 | COMPOSITIONS AND METHODS FOR CHARACTERIZING LYMPHOMA AND RELATED CONDITIONS | Non-Final OA | The General Hospital Corporation |
| 18534106 | METHODS FOR DETECTING MODIFIED NUCLEOTIDES | Non-Final OA | CAMBRIDGE ENTERPRISE LIMITED |
| 18722508 | DETECTION OF GENETIC AND EPIGENETIC INFORMATION IN A SINGLE WORKFLOW | Non-Final OA | Foundation Medicine, Inc. |
| 18712646 | METHODS AND SYSTEMS FOR REPORTING CLINICALLY-ACTIONABLE POTENTIAL GERMLINE PATHOGENIC VARIANT SEQUENCES | Non-Final OA | Foundation Medicine, Inc. |
| 18561986 | ENHANCER OLIGONUCLEOTIDES FOR NUCLEIC ACID HYBRIDIZATION | Non-Final OA | Roche Sequencing Solutions, Inc |
| 18029937 | METHOD FOR VIRUS DETECTION | Non-Final OA | Qiagen GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy